Investorideas.com


Be a guest or sponsor our podcasts - learn more about us : 800 665 0411


Share on StockTwits

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 417 (OTC: CSUI) (NYSE: ACB) (TSX: ACB), (CSE: CURA) (TSXV: RTI)

 

Delta, Kelowna, BC - May 21, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/052120-StocksToWatch.mp3

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 417 (OTC: CSUI) (NYSE: ACB) (TSX: ACB), (CSE: CURA) (TSXV: RTI)

SHARE PODCAST:      

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

Today's podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today's podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.

The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.

In today's podcast we will be looking at a few public company announcements.

Cannabis Suisse Corp. (OTC: CSUI), being a fully licensed Swiss cannabis cultivation and distribution company for recreational tobacco products and medical CBD oils, announced that it has signed a distribution agreement with Hanfpost GmbH, one of Swiss leading online sellers of cannabis products.

The two-year agreement is aimed at building a long-term partnership. The cooperation is expected to bring continuous stable revenue from a wide selection of Cannabis Suisse' product lines, marketed under the Alpine Cannabis brand. These include premium smoking weed, pre-rolled joints, CBD oils and pure base liquid hemp.

Under the terms of this agreement, Cannabis Suisse becomes one of the suppliers of Hanfpost GmbH. Cannabis Suisse intends to provide the best quality for the lowest price, so the Company hopes to occupy a huge part of Hanfpost website.

The partnership between two companies is not only based on financial targets but is also believed to build solid trust in Cannabis Suisse' consistent and sustainable quality and dedication to bringing premium products to the Swiss home market. Switzerland has the highest allowed legislative THC content in Europe (1%) for sales of cannabis products in retail outlets (without medical receipt). This makes Switzerland a perfect geographic location to manufacture cannabis products, with the intent to scale the business into worldwide distribution. The Company will be provided with the platform to establish new business relationships, make Alpine Cannabis trademark recognizable, bring its high-quality CBD products to broader range of consumers, present the product in the growing market. Cannabis Suisse Corp. intends to become a leader in the Swiss CBD market. The Company hopes to quickly expand its customer base in neighboring countries as well.

The choice of Hanfpost GmbH for a strategic partnership is not random. Among other advantages of this internet distributor there is an opportunity to create a customer account, a list of wishes and selected products, a wide assortment of goods for wholesale and retail purchase, round-the-clock work, useful and relevant information about CBD products, latest industry news, free delivery from 99 CHF or the takeaway store in Grenchen.

All the products represented on the website are made with great love and experience exclusively in Switzerland. Hanfpost suppliers specialize in the production of cannabis products with a THC level below 1%, completely abandoning fungicides and herbicides. All the goods are subject to stringent quality controls, everything is checked by the accredited laboratories and registered with the Federal Health Office, meaning it is 100% compliant with Swiss legislation.

Due to a proven track record, deep knowledge of the local market and a leading distribution platform in Switzerland, Hanfpost is an excellent partner for strategic access to a strong and fast-growing cannabis market with a long-term growth potential.

The agreement allows Cannabis Suisse Corp. to increase the potential for additional income and expand the company's operations without increasing expenses. Such cooperation involves additional income not only of the Company, but also of its shareholders, as it strengthens the CSUI market position.

Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, and Reliva, LLC a leader in the sale of hemp-derived CBD products in the United States, announced that they have entered into an agreement pursuant to which Aurora will acquire all of the issued and outstanding membership interests of Reliva. Under the terms of the agreement, members of Reliva will receive approximately US$40 million of Aurora common shares. The transaction also includes a potential earn-out of up to a maximum of US$45 million payable in Aurora shares, cash or a combination thereof, over the next two years contingent upon Reliva achieving certain financial targets.

The structure of the earn-out is designed to align risk and reward between Aurora shareholders and Reliva management to focus on continued strong operational and financial execution. The transaction is expected to close, subject to customary closing conditions, in June 2020 . It is anticipated that the transaction will be immediately accretive to Aurora on an Adjusted EBITDA basis, consistent with Aurora's objective to drive towards Adjusted EBITDA profitability in its fiscal first quarter of 2021.

The transaction will combine Aurora's leading Canadian recreational brands, and Canadian and European medical market position with the leading U.S. hemp-derived CBD brand in retail stores. Consistent with the announcement of Aurora's business transformation plan in February 2020 , the Company has aligned its U.S. investment strategy with the goals of the transformation plan, namely: financial discipline, operational focus, and strong execution.

The transaction represents the culmination of a multi-month strategic evaluation of the U.S. hemp-derived CBD industry. Reliva stood out among a lengthy list of potential partners for its: (1) focus on regulatory, testing and compliance protocols; (2) proven management team with extensive experience selling and marketing regulated consumer packaged goods; (3) deep relationships with critical trade partners that provide a U.S. national distribution footprint; and (4) financial discipline and track record of growth and profitability. Together with Reliva, Aurora is expected to be positioned as a meaningful player in the United States , the world's largest cannabinoid market.

"Together, Aurora and Reliva will partner to create an international cannabinoid leader that we believe can deliver robust revenue and profitable growth," said Michael Singer , Executive Chairman and Interim CEO of Aurora. "We have taken the time necessary to carefully assess the Company's entry into the U.S. market and we firmly believe that the combination with Reliva will create significant long-term value as Reliva provides us options to grow in hemp-derived CBD internationally. Similar to Aurora, Reliva has a strong entrepreneurial spirit and successful track record of transforming categories and creating growth brands. We welcome Miguel Martin and his team to Aurora, and look forward to the opportunity to increase our operating scale, international reach, and product and brand diversity as we drive to Adjusted EBITDA profitability. We plan to capitalize on each company's market leadership and sales infrastructure to drive higher revenue growth than either company could independently accomplish."

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today announced that retail locations in Massachusetts will re-open for adult-use purchases starting on May 25th, 2020.

Dispensary locations in Ware and Oxford will be open for regular hours from 9 AM to 8 PM Monday through Saturday, and 10 AM to 5 PM Sunday. The Provincetown location will be open for new summer hours from 9 AM to 9 PM Monday through Sunday.

"We are pleased that our three adult use dispensaries in Ware, Oxford and Provincetown are among the first of Commonwealth businesses allowed to re-open on May 25, and we appreciate the Governor and Lt. Governor's decision," said Patrik Jonsson, president of Curaleaf Massachusetts. "We're very much looking forward to resuming serving our customers with the quality products they have come to rely on, and also getting our people back to work. We expect sales to be brisk as a result of pent up demand, and we are working closely with the Cannabis Control Commission and the Massachusetts Department of Health to comply with all guidelines surrounding our reopening."

Curaleaf's employees will continue to exercise all appropriate measures to ensure the safety of their customers and staff. This includes enforcement of social distancing, mandatory face masks for all employees and customers, increased sanitation and hygiene measures, and the use of technology to minimize contact during the purchasing process as well as other day-to-day store operations.

Radient Technologies Inc. (TSXV: RTI) (OTCQX: RDDTF), a global manufacturer of high quality cannabinoid-based ingredients, formulations and products, announced the launch of bioU, a scientifically formulated brand exclusively sold to Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart Inc., and available across Canada.

Radient's first products released under the bioU label will be the Uspray series of high quality, scientifically formulated oral cannabis sprays. bioU Uspray will have three formulations available to consumers on the Medical Cannabis by Shoppers online platform; a THC dominant formula with 30mg/mL of THC and 1 mg/mL of CBD, a CBD dominant formula with 20 mg/mL CBD and 1 mg/mL THC, and a balanced formula with 10 mg/mL THC and 10 mg/mL CBD. All bioU products have been designed by Radient to retain cannabinoids and terpenes while providing high levels of purity and consistency.

"We are very excited to launch this line of products with Medical Cannabis by Shoppers. This is a key step for the Company in forging a long-term and successful partnership with one of Canada's most trusted names in retail. We look forward to broadening our product offering with Shoppers and giving consumers access to the first branded products from Radient," said Denis Taschuk, Chief Executive Officer, Radient Technologies.

Radient plans on expanding the products available under the bioU brand over the coming months. The bioU brand will use Radient's proprietary broad spectrum cannabinoid extracts along with an extensive library of internally developed formulations. Radient's unique, continuous-flow extraction process has been proven to achieve a higher recovery of active compounds from the cannabis plant (up to 99%) than other extraction methods. It has lower risk of cannabinoid degradation during processing which allows products to maintain shelf life for a longer period of time, and has a high level of product consistency. Combining its unique extraction technology with stringent quality control systems and decades of botanical ingredient manufacturing experience, Radient produces a variety of broad spectrum cannabinoid formulations, ingredients and products that meet the highest standards of quality and safety.

Once again, today's podcast was sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.

The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

Disclosure: CSUI is a paid month news and social media cannabis stock . More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/investorideas_potcast/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411


Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories